Form 4 Moderna, Inc. For: Jul 31 Filed by: AFEYAN NOUBAR

Go back to Form 4 Moderna, Inc. For: Jul 31 Filed by: AFEYAN NOUBAR

Deutsche Bank Upgrades Moderna (MRNA) to Hold, 'a more troublesome Winter’s Tale, but up to Hold'

August 6, 2024 4:18 PM EDT

Deutsche Bank analyst Emmanuel Papadakis upgraded Moderna (NASDAQ: MRNA) from Sell to Hold with a price target of $80.00 (from $85.00).

The analyst comments "We update after Q2s difficult print (Moderna: Q2 first take. Set to be pursued by many bears?*: winter reckoning arrives early (01/08/24)), which delivered the triple-blow of downgraded revenue, reduced gross margin and maintained... More